Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.25.0.1
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Dec. 22, 2024
Nov. 13, 2023
Sep. 28, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Jun. 30, 2024
Nov. 20, 2023
May 04, 2021
Subsidiary, Sale of Stock [Line Items]                  
Common stock, authorized       50,000,000   50,000,000 50,000,000 40,000,000 50,000,000
Common stock, par value       $ 0.001   $ 0.001 $ 0.001   $ 0.001
preferred stock, authorized       2,000,000   2,000,000 2,000,000   2,000,000
Preferred stock, par value       $ 0.001   $ 0.001 $ 0.001   $ 0.001
Proceeds from issuance or sale of equity           $ 15,000,000.0      
Financing fees       $ 37,597          
Securities Purchase Agreement [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Issuance of common stock 15,151,514                
Stock issued value per unit $ 0.99                
Common Stock [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Issuance of common stock       15,151,514 300,000        
Common Stock [Member] | Loan and Sercurity Agreement [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Issuance of common stock   300,000              
Private Placement [Member]                  
Subsidiary, Sale of Stock [Line Items]                  
Issuance of common stock     2,264,650            
Proceeds from warrants     $ 6,600,000            
Stock issued value per unit     $ 2.935            
Proceeds from issuance or sale of equity $ 15,000,000.0   $ 6,300,000            
Financing fees $ 38,000   $ 300,000            
Warrant exercise price per share     $ 4.215